Schizophrenia research
Treatments for schizophrenia are effective for only half of patients and can cause severe side effects. TRC offers wide-ranging GPCR modulators to help you investigate novel schizophrenia drug targets.
Shop nowReview the latest neural cells and models, research chemicals and reference standards to support your research on mental disorders.
Treatments for schizophrenia are effective for only half of patients and can cause severe side effects. TRC offers wide-ranging GPCR modulators to help you investigate novel schizophrenia drug targets.
Shop nowUnderstanding the neuropathological changes associated with substance abuse is crucial to developing improved treatments. TRC offers diverse addiction-relevant modulators of 5-HT, GABA and dopamine receptors to support this work.
Shop nowDepression, anxiety and stress are debilitating mental disorders. From novel depression biomarkers to modulators of relevant targets such as dopamine, GABA and 5HT receptors, TRC supports your research and discovery.
Shop nowControlled substances such as hallucinogens and psychedelics are increasingly being used to treat depression and addiction. Choose from diverse TRC controlled substances including psilocybin and MDMA.
Shop nowStable isotope labelled (SIL) molecules are invaluable for ADME and biomarker investigations. Select from TRC's extensive SIL neurochemicals including D, C, N, O, S and combinations designed with your use case in mind.
Shop nowCan’t find what you need on our website or want to discuss a specific project? Make use of TRC's custom synthesis problem-solving skills. Our 250+ chemists are up to the challenge!
Get in touchYour punchout session will expire in1 min59 sec.
Select "Continue session" to extend your session.